Implantación transfemoral de prótesis valvular aórtica en pacientes portadores de prótesis mitral mecánica

Garcı́a, Eulogio; Albarrán, Agustín; Heredia-Mantrana, Jerónimo; Guerrero-Pinedo, Fernando; Rodríguez, Julio César; Hernández‐Antolín, Rosana; Tascón, Juan; Macaya, Carlos

doi:10.1016/j.recesp.2011.02.022

Cited by 13 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…7 Additionally, rigidity of the prosthetic mitral ring and the short distance between the aortic ring and the mitral prosthesis interferes with the correct functioning of the mitral prosthesis, thus producing a "watermelon seed effect," with subsequentially risk of aortic prosthesis embolization. 7,8 Therefore, several precautions must be considered when performing TAVI in those with a pre-existing MMP, namely, extensive MSCT mitro-aortic assessment, close balloon behavior monitorization, choosing appropriate fluoroscopic projection, and TOE-guided aortic prosthesis positioning. 8,9 Postdeployment dilation is not recommended due to the risk of impingement on the mitral prosthesis ring, potentially hindering disc closure.…”

Section: Discussionmentioning

confidence: 99%

“…7,8 Therefore, several precautions must be considered when performing TAVI in those with a pre-existing MMP, namely, extensive MSCT mitro-aortic assessment, close balloon behavior monitorization, choosing appropriate fluoroscopic projection, and TOE-guided aortic prosthesis positioning. 8,9 Postdeployment dilation is not recommended due to the risk of impingement on the mitral prosthesis ring, potentially hindering disc closure. 10 Certain features to accommodate the valve should also be considered:…”

Section: Discussionmentioning

confidence: 99%

“…Since the first TAVI trials, several reports have shown that TAVI in patients with MMP is safe and can produce acceptable results 3,5,[7][8][9][10][11][12][13][14] (Supporting Information S1: Table 1). In most cases, a self-expanding CoreValve was used 5,8,15 and, in the cases that the balloon-expandable Edwards Sapien was used (Edwards Lifesciences), the transapical route was preferred, 16 although transfemoral route has also been reported. 8,11,15 Noteworthy distinctions of this case report from previous cases include a smaller mitro-aortic distance in our patient (2.8 vs.…”

Section: Discussionmentioning

confidence: 99%

“…In most cases, a self-expanding CoreValve was used 5,8,15 and, in the cases that the balloon-expandable Edwards Sapien was used (Edwards Lifesciences), the transapical route was preferred, 16 although transfemoral route has also been reported. 8,11,15 Noteworthy distinctions of this case report from previous cases include a smaller mitro-aortic distance in our patient (2.8 vs.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Combined transcatheter aortic valve and tricuspid valve‐in‐valve implantation in a patient with a mitral mechanical prosthesis

Lima,

Brito,

Almeida

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

Despite progressively uncommon in Western countries, rheumatic heart disease still portrays a significant global burden. In elderly or high‐surgical risk patients, plurivalvular disease may require a complex percutaneous approach. Transcatheter aortic valve implantation (TAVI) in patients with previous monoleaflet mitral prosthesis is challenging due to interference between the aortic valve and the rigid mitral mechanical prosthesis “ring.” Prior cases report the use of CoreValve or Edwards Sapien aortic valves in patients with adequate mitro‐aortic distance. Performing a second major procedure, such as tricuspid valve‐in‐valve (TVIV), sequentially during a single percutaneous intervention, increases treatment complexity. An 83‐year‐old woman with rheumatic heart disease, with previous implantation of a Bjork–Shiley monoleaflet mitral prosthesis, and Carpentier‐Edwards 29 tricuspid bioprosthesis presented with decompensated heart failure due to severe aortic stenosis and tricuspid bioprosthesis stenosis. After HeartTeam discussion, the patient was deemed as inoperable due to a prohibitive surgical risk. As an alternative, a TAVI (Navitor FlexNav) and a transcatheter TVIV replacement (Edwards Sapiens 3 Ultra) were discussed and proposed, with both techniques being performed sequentially in a single procedure. TAVI in a patient with a previous monoleaflet mitral mechanical prosthesis and TVIV may be a feasible approach in inoperable patients with plurivalvular disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Combined transcatheter aortic valve and tricuspid valve‐in‐valve implantation in a patient with a mitral mechanical prosthesis

Lima,

Brito,

Almeida

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…A significant reduction or even the absence of mitroaortic space to accommodate the balloon-expanded valve and the presence of a mechanical structure instead of fibrous tissue can limit the expansion of the percutaneous valve. 8 , 9 Hence, a pre-existing prosthetic valve or ring was considered an exclusion criterion in clinical trials such as the PARTNER II trial (Edwards SAPIEN valve) and the Medtronic CoreValve U.S. Pivotal Trial. 10 , 11…”

Section: Discussionmentioning

confidence: 99%

Transcatheter Self-expandable Aortic Valve (Portico) Implantation in a Patient with Previous Mitral Valve Replacement: A Case Report

Korkmaz

Gürsoy

İleri

et al. 2019

JTHC

View full text Add to dashboard Cite

Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or who are unsuitable candidates for open-heart surgery. However, concerns exist over treating patients who have undergone previous mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a case in which a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement was successfully treated with TAVI using a Portico valve, which is under-researched. J Teh Univ Heart Ctr 2019;14(2):85-89 This paper should be cited as: Korkmaz A, Gürsoy HT, İleri M, Uçar Elalmış Ö, Güray Ü. Transcatheter Self-expandable Aortic Valve (Portico) Implantation in a Patient with Previous Mitral Valve Replacement: A Case Report. J Teh Univ Heart Ctr 2019;14(2):85-89.

show abstract

Transcatheter implantation of a newly designed aortic prosthesis in a patient with a mechanical mitral valve

Minol

Veulemanns

Zeus

et al. 2014

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

patient underwent off-pump stage II palliation at 3 months of age with the placement of a right Glenn shunt, central shunt placement, and ligation of the left-sided superior vena cava above the level of the azygos vein. Postoperative echocardiography showed right ventricular hypertrophy with preserved systolic function, mild neoaortic valve insufficiency, unobstructed PA flow, and mild to moderate obstruction at the junction of the neoaorta and the native descending aorta.At 4 years of age, the patient underwent pericardial patch augmentation of the neoaorta with excision of the previously fixed ductus arteriosus, anastomosis of the azygos continuity of the inferior vena cava to the left PA (Kawashima procedure), central shunt takedown, and augmentation of the central PA with a 12 mm GORE-TEX graft (W. L. Gore & Associates, Newark, Del) on cardiopulmonary bypass. Her postoperative course was uneventful, with echocardiography showing minimal neoaortic valve regurgitation with no obstruction of the neoaorta, PAs, Glenn, and Kawashima anastomoses. Pathologic examination of the excised ductus arteriosus tissue is shown in Figure 2, C.The patient presented at 8 years of age with increasing cyanosis secondary to progressive pulmonary arteriovenous malformations, and thus underwent connection of the hepatic veins to the right PA by using a 16-mm GORE-TEX graft with an uneventful postoperative course.At most recent follow-up, the patient is 8 years old and growing well. There is excellent right ventricular systolic function, mild tricuspid regurgitation, and no neoaortic valve regurgitation on echocardiography. The

show abstract

Implantación transfemoral de prótesis valvular aórtica en pacientes portadores de prótesis mitral mecánica

Cited by 13 publications

References 8 publications

Combined transcatheter aortic valve and tricuspid valve‐in‐valve implantation in a patient with a mitral mechanical prosthesis

Combined transcatheter aortic valve and tricuspid valve‐in‐valve implantation in a patient with a mitral mechanical prosthesis

Transcatheter Self-expandable Aortic Valve (Portico) Implantation in a Patient with Previous Mitral Valve Replacement: A Case Report

Transcatheter implantation of a newly designed aortic prosthesis in a patient with a mechanical mitral valve

Contact Info

Product

Resources

About